Host-related factors and cancer: Malnutrition and non-Hodgkin lymphoma.
cancer metabolic syndrome
diffuse large B-cell lymphoma
frailty
non-Hodgkin lymphoma
nutritional status
Journal
Hematological oncology
ISSN: 1099-1069
Titre abrégé: Hematol Oncol
Pays: England
ID NLM: 8307268
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
revised:
24
02
2022
received:
29
11
2021
accepted:
05
04
2022
pubmed:
11
4
2022
medline:
10
8
2022
entrez:
10
4
2022
Statut:
ppublish
Résumé
Assessment of host-related factors is a crucial aspect in the comprehensive management of cancer patients. A distinct nutritional disturbance linked to cancer has been recognized to be associated with negative outcomes. However, compared to solid tumors, only a limited number of studies have looked specifically at nutritional issues in the field of lymphoma. The aim of this review is to integrate the current knowledge on interactions between malnutrition and lymphoma and address most relevant and pertinent questions. We first provide a literature review on the mutual biological relationship between malnutrition and lymphoma. Next, we explore the overlap between malnutrition, sarcopenia, cachexia and frailty in lymphoma studies. In addition, we summarize the clinical assessment scales used to measure malnutrition in lymphoma subjects. Furthermore, we address the problem of nutritional interventions aimed at patients who are candidates for treatment for lymphoma. Malnutrition can arise as a consequence of lymphoma disease and can in turn promote lymphomagenesis, negatively affect the response to therapy and favor adverse event to treatment. There is increasing evidence that malnutrition, sarcopenia and cachexia in lymphoma are intimately inter-related and are a hallmark of frailty. A variety of different tools are recorded with the apparent ability to describe nutritional status and to impact prognosis in lymphoma patients. Finally, a network of prognostic host- and disease-related factors is proposed where malnutrition can interact with each other in complex ways.
Identifiants
pubmed: 35398917
doi: 10.1002/hon.3002
pmc: PMC9544175
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
320-331Subventions
Organisme : Open Access Funding provided by Universita degli Studi di Palermo within the CRUI-CARE Agreement.
Informations de copyright
© 2022 The Authors. Hematological Oncology published by John Wiley & Sons Ltd.
Références
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
Hematol Oncol. 2022 Aug;40(3):320-331
pubmed: 35398917
Eur J Haematol. 2002 Feb;68(2):91-100
pubmed: 12038454
Blood. 2017 Oct 19;130(16):1800-1808
pubmed: 28774879
Int J Mol Sci. 2020 Sep 21;21(18):
pubmed: 32967158
Eur J Clin Nutr. 2016 Jan;70(1):41-6
pubmed: 26330148
JPEN J Parenter Enteral Nutr. 2019 Jan;43(1):32-40
pubmed: 30175461
Clin Geriatr Med. 2011 Feb;27(1):27-37
pubmed: 21093720
Nat Aging. 2021 Jan;1(1):36-46
pubmed: 34476409
Ann Hematol. 2015 Aug;94(8):1389-400
pubmed: 25869028
J Clin Oncol. 2010 Sep 10;28(26):4019-21
pubmed: 20697081
Blood. 2006 Jan 1;107(1):265-76
pubmed: 16150940
Ann Hematol. 2019 Feb;98(2):401-411
pubmed: 30413902
Lancet Oncol. 2011 May;12(5):489-95
pubmed: 21296615
Cancer Res. 2012 Sep 15;72(18):4733-43
pubmed: 22846913
Am J Clin Nutr. 2005 Oct;82(4):777-83
pubmed: 16210706
J Clin Oncol. 2010 Sep 10;28(26):4022-8
pubmed: 20644094
CA Cancer J Clin. 2017 Sep;67(5):362-377
pubmed: 28731537
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):366-378
pubmed: 27913503
Blood. 2015 Jan 1;125(1):22-32
pubmed: 25499448
Clin Nutr. 2008 Feb;27(1):5-15
pubmed: 18061312
BMC Cancer. 2020 May 18;20(1):439
pubmed: 32423395
JPEN J Parenter Enteral Nutr. 2013 Nov;37(6):802-7
pubmed: 23969411
Cancer Causes Control. 2005 Dec;16(10):1203-14
pubmed: 16215871
Blood. 2009 Sep 24;114(13):2730-2
pubmed: 19638620
J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):567-576
pubmed: 27104110
Support Care Cancer. 2020 Mar;28(3):1441-1448
pubmed: 31273503
Ann Surg Oncol. 2017 Dec;24(13):4067-4075
pubmed: 28975525
Am J Clin Oncol. 2019 Feb;42(2):202-207
pubmed: 30499839
Haematologica. 2015 May;100(5):571-4
pubmed: 25944637
Br J Haematol. 2021 Feb;192(3):551-559
pubmed: 33236363
Curr Oncol. 2021 Mar 23;28(2):1325-1337
pubmed: 33806839
Nutr Clin Pract. 2005 Aug;20(4):369-76
pubmed: 16207677
Oncologist. 2017 May;22(5):554-560
pubmed: 28408622
Leuk Lymphoma. 2014 Apr;55(4):817-23
pubmed: 23781925
Sci Rep. 2020 Aug 14;10(1):13814
pubmed: 32796953
Blood. 2007 Mar 1;109(5):1857-61
pubmed: 17105812
Eur J Haematol. 2014 Jul;93(1):9-18
pubmed: 24520908
Ann Hematol. 2015 Dec;94(12):2043-53
pubmed: 26385388
Eur J Oncol Nurs. 2005;9 Suppl 2:S51-63
pubmed: 16437758
Rev Endocr Metab Disord. 2020 Sep;21(3):307-313
pubmed: 32766943
J Thorac Dis. 2018 Sep;10(9):5298-5307
pubmed: 30416777
Ann Hematol. 2005 Aug;84(8):510-6
pubmed: 15834569
Public Health Nutr. 2014 Jul;17(7):1531-7
pubmed: 23659580
Ann Oncol. 2017 Sep 1;28(9):2107-2118
pubmed: 28911059
Clin Nutr. 2020 Jul;39(7):1983-1987
pubmed: 32425292
Int J Hematol. 2011 Aug;94(2):178-184
pubmed: 21800075
Blood. 2006 Jun 15;107(12):4643-9
pubmed: 16493005
Nutr Cancer. 2014;66(2):225-33
pubmed: 24405259
CA Cancer J Clin. 2006 Nov-Dec;56(6):323-53
pubmed: 17135691
Curr Hematol Malig Rep. 2019 Jun;14(3):164-170
pubmed: 31093888
Blood. 1994 Oct 15;84(8):2472-9
pubmed: 7919367
Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1577-84
pubmed: 20501772
Am J Epidemiol. 2005 Dec 15;162(12):1162-73
pubmed: 16269580
Dis Colon Rectum. 2015 Nov;58(11):1048-57
pubmed: 26445177
Cancer. 2009 Oct 1;115(19):4547-53
pubmed: 19562776
Cancer Treat Rev. 2014 Jul;40(6):685-91
pubmed: 24321611
Clin Nutr. 2017 Feb;36(1):11-48
pubmed: 27637832
Nutr Hosp. 2005 Jan-Feb;20(1):38-45
pubmed: 15762418
Ann Hematol. 2020 Dec;99(12):2859-2868
pubmed: 32970194
Nutr Cancer. 2021;73(11-12):2554-2567
pubmed: 33121266
Hematol Oncol. 2016 Dec;34(4):184-192
pubmed: 26052918
Ann Oncol. 2014 Aug;25(8):1635-42
pubmed: 24562443
J Geriatr Oncol. 2021 Jan;12(1):6-21
pubmed: 32616384
Oncologist. 2021 Feb;26(2):120-132
pubmed: 33230948
Cancer Med. 2018 Apr 13;:
pubmed: 29654631
J Cancer Res Clin Oncol. 2022 Jul;148(7):1789-1801
pubmed: 34415426
Oncotarget. 2017 Sep 11;8(44):76740-76748
pubmed: 29100345
Leuk Lymphoma. 2009 Dec;50(12):1999-2004
pubmed: 19860627
Bone Marrow Transplant. 2019 Dec;54(12):2102-2109
pubmed: 31455897
Cancer Cell Int. 2020 Sep 15;20:455
pubmed: 32973400
Hematology Am Soc Hematol Educ Program. 2010;2010:255-8
pubmed: 21239802
Br J Cancer. 2005 Oct 3;93(7):811-6
pubmed: 16160698
Cancer Res. 2011 Jul 15;71(14):4898-907
pubmed: 21632552
Int J Cancer. 2008 May 1;122(9):2062-70
pubmed: 18167059
Ann Hematol. 2018 Jun;97(6):999-1007
pubmed: 29427185
Wien Klin Wochenschr. 2017 Jun;129(11-12):411-419
pubmed: 27637206
Hemasphere. 2020 Jan 15;4(1):e332
pubmed: 32072148
Support Care Cancer. 2012 Aug;20(8):1919-28
pubmed: 22314972
Int J Hematol. 2016 Oct;104(4):485-90
pubmed: 27393279
Front Oncol. 2018 Apr 16;8:103
pubmed: 29713614
Leuk Lymphoma. 2015 Jul;56(7):1959-68
pubmed: 25363401
Ann Hematol. 2020 Jan;99(1):113-119
pubmed: 31768678
Cancer Treat Rev. 2013 Aug;39(5):534-40
pubmed: 22995477
Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):779-86
pubmed: 15159310
Hematol Oncol. 2020 Aug;38(3):309-317
pubmed: 32223021
Yonsei Med J. 2014 Nov;55(6):1568-75
pubmed: 25323893
Ann Hematol. 2014 Aug;93(8):1305-12
pubmed: 24590536
PLoS One. 2015 Jun 01;10(6):e0127589
pubmed: 26030144
Eur J Clin Nutr. 2018 Sep;72(9):1255-1259
pubmed: 30185853
Cochrane Database Syst Rev. 2009 Jan 21;(1):CD002920
pubmed: 19160213
Leuk Lymphoma. 2010 May;51(5):813-21
pubmed: 20367565
N Engl J Med. 1993 Sep 30;329(14):987-94
pubmed: 8141877